Omega Healthcare Investors (NYSE:OHI) Price Target Raised to $33.00

Omega Healthcare Investors (NYSE:OHI) had its target price lifted by equities research analysts at Scotiabank from $32.00 to $33.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s target price points to a potential downside of 3.06% from the company’s current price.

OHI has been the topic of several other research reports. JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a research note on Monday, May 6th. Wells Fargo & Company raised Omega Healthcare Investors to a “strong-buy” rating in a research note on Friday, June 14th. Citigroup raised Omega Healthcare Investors from a “neutral” rating to a “buy” rating and lifted their price target for the company from $32.00 to $35.00 in a research note on Friday, March 22nd. Finally, Truist Financial lifted their price target on Omega Healthcare Investors from $32.00 to $33.00 and gave the company a “hold” rating in a research note on Wednesday, June 26th. Nine research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors presently has an average rating of “Hold” and a consensus price target of $33.65.

Omega Healthcare Investors Stock Performance

OHI stock opened at $34.04 on Tuesday. The business’s 50-day moving average price is $32.20 and its two-hundred day moving average price is $31.13. The company has a current ratio of 6.68, a quick ratio of 6.68 and a debt-to-equity ratio of 1.36. The firm has a market cap of $8.41 billion, a PE ratio of 30.67, a P/E/G ratio of 1.24 and a beta of 0.97. Omega Healthcare Investors has a 1-year low of $27.53 and a 1-year high of $34.77.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of institutional investors have recently bought and sold shares of OHI. Versant Capital Management Inc acquired a new position in Omega Healthcare Investors during the second quarter worth approximately $26,000. MeadowBrook Investment Advisors LLC acquired a new position in Omega Healthcare Investors during the fourth quarter worth approximately $31,000. GAMMA Investing LLC acquired a new position in Omega Healthcare Investors during the fourth quarter worth approximately $35,000. Highlander Capital Management LLC increased its position in Omega Healthcare Investors by 150.0% during the fourth quarter. Highlander Capital Management LLC now owns 1,250 shares of the real estate investment trust’s stock worth $38,000 after buying an additional 750 shares during the last quarter. Finally, WFA Asset Management Corp acquired a new position in Omega Healthcare Investors during the first quarter worth approximately $39,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.